| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BELLUS Health Inc (TO: BLU)
BLU Technical Analysis
5
| As on 29th Jun 2023 BLU STOCK Price closed @ 19.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.38 & Strong Buy for SHORT-TERM with Stoploss of 8.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BLUSTOCK Price
| Open | 19.51 | Change | Price | % |
| High | 19.61 | 1 Day | -0.02 | -0.10 |
| Low | 19.24 | 1 Week | 0.04 | 0.21 |
| Close | 19.48 | 1 Month | 0.05 | 0.26 |
| Volume | 28700 | 1 Year | 11.59 | 146.89 |
| 52 Week High 19.84 | 52 Week Low 6.96 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| CNQ | 42.50 | 0.05% |
| ENB | 59.43 | 1.49% |
| BB | 5.27 | 23.13% |
| ABX | 22.22 | 1.41% |
| TWM | 0.12 | 0.00% |
| FCU | 0.74 | -2.63% |
| PPL | 52.36 | 0.89% |
| CVE | 20.71 | 0.24% |
| TD | 76.09 | 0.44% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| BLU Daily Charts |
BLU Intraday Charts |
Whats New @ Bazaartrend |
BLU Free Analysis |
|
|
BLU Important Levels Intraday
| RESISTANCE | 20.19 |
| RESISTANCE | 19.96 |
| RESISTANCE | 19.82 |
| RESISTANCE | 19.68 |
| SUPPORT | 19.28 |
| SUPPORT | 19.14 |
| SUPPORT | 19.00 |
| SUPPORT | 18.77 |
BLU Forecast December 2024
| 4th UP Forecast | 24.1 |
| 3rd UP Forecast | 22.62 |
| 2nd UP Forecast | 21.7 |
| 1st UP Forecast | 20.79 |
| 1st DOWN Forecast | 18.17 |
| 2nd DOWN Forecast | 17.26 |
| 3rd DOWN Forecast | 16.34 |
| 4th DOWN Forecast | 14.86 |
BLU Weekly Forecast
| 4th UP Forecast | 22.52 |
| 3rd UP Forecast | 21.55 |
| 2nd UP Forecast | 20.94 |
| 1st UP Forecast | 20.34 |
| 1st DOWN Forecast | 18.62 |
| 2nd DOWN Forecast | 18.02 |
| 3rd DOWN Forecast | 17.41 |
| 4th DOWN Forecast | 16.44 |
BLU Forecast2024
| 4th UP Forecast | 45.69 |
| 3rd UP Forecast | 37.28 |
| 2nd UP Forecast | 32.09 |
| 1st UP Forecast | 26.89 |
| 1st DOWN Forecast | 12.07 |
| 2nd DOWN Forecast | 6.87 |
| 3rd DOWN Forecast | 1.68 |
| 4th DOWN Forecast | -6.73 |
BELLUS Health Inc ( TO Canada Symbol : BLU )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BLU Business Profile
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada. Address: 275 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4A7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service